BOSTON, June 21 (Korea Bizwire) — Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities has been selected for the prestigious CRO Leadership Award 2023 for exceeding biotech customer expectations in the “Compatibility” category. The award will be officially presented at the 2023 CRO Leadership Awards Ceremony, June 27th in Boston. The global award is [...]
BOSTON, May 29 (Korea Bizwire) — Novotech, the leading Asia Pacific centred biotech CRO is sponsoring the BIO 2023 APAC Summit, and the Endpoints session on Forging New Biotech Ties with China. Novotech CCO Barry Murphy is a panelist on the APAC Summit session Diversity and Beyond – Tapping the potential of the Asia Pacific for Clinical Trials. Novotech, a biotech [...]
CHICAGO, May 25 (Korea Bizwire) — Novotech, the leading Asia Pacific centred biotech CRO is sponsoring key oncology focussed expert events for ASCO: a pre-ASCO Summit with eChina Health, and a webinar panel discussion on accelerating development of advanced therapies with Endpoints. Meet with the Novotech team at ASCO here Novotech, which has more than [...]
SYDNEY, Australia, May 8 (Korea Bizwire) — Novotech, the leading Asia Pacific centred biotech CRO conducted a survey of global biotech professionals, in partnership with Citeline, on their current and future clinical pipeline prospects, the main challenges of clinical trials, and perspective shifts regarding study locations. A key finding from the report is that cost [...]
SYDNEY, Australia, April 13 (Korea Bizwire) — Novotech, the leading Asia Pacific centred biotech CRO joins oncology leaders at the eChinaHealth panelist session and dinner at AACR. The discussion will focus on collaboration experience with China’s cancer research sector. (Register here) The panelist session is part of the AACR Annual Meeting, April 14 – 19, 2023, [...]
SINGAPORE, April 4 (Korea Bizwire) — Novotech, the leading Asia Pacific centred biotech CRO has commissioned GlobalData to report on the evolving FDA approval processes for biotechs in Asia Pacific, Europe, and US, including typical impediments to success. The GlobalData report outlines the global approval landscape, pathways to approval, some frequent missteps to avoid, the [...]
SINGAPORE, March 15 (Korea Bizwire) — Novotech, the leading Asia Pacific centred biotech CRO has published a new report on the current status of clinical trials for multi-specific monoclonal antibodies (Mabs) globally including an analysis of growth hubs across Asia Pacific, Europe, and US. The new report Multi-Specific Monoclonal Antibodies – Global Clinical Trial Landscape can be downloaded [...]